Fierce Pharma

APRIL 5, 2024

Vertex CEO Reshma Kewalramani, M.D., made $20.6 million in 2023, which was an increase of 30% from her $15.9 million pay in 2022.

355

355

MedCity News

APRIL 5, 2024

Biolinq raked in $58 million in capital this week. The company is developing a wearable patch that uses electrochemical sensors to measure a person’s glucose levels from the intradermal space just beneath the surface of their skin. The post Biolinq Snags $58M for ‘Smallest Biosensor in the World’ appeared first on MedCity News.

122

122

Fierce Pharma

APRIL 5, 2024

Inclusive Innovation: Key to the Future of Healthcare jpiatt Fri, 04/05/2024 - 10:37

Healthcare 312

Healthcare Healthcare 312

MedCity News

APRIL 5, 2024

Check out news from Alpha Sophia, Biolinq, EarliTec Diagnostics, and Nourish. The post StartUPDATES: New developments from Healthcare Startups appeared first on MedCity News.

Healthcare 119

Healthcare Healthcare 119

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

APRIL 5, 2024

Despite Boehringer Ingelheim’s 2021 Humira biosimilar approval being heralded by some analysts as a “landmark achievement” for the field, the drug—dubbed Cyltezo—has struggled to gain traction than | Facing lackluster Cyltezo sales, Boehringer Ingelheim will prune its ranks in the U.S. and adopt a different way of marketing its Humira biosimilar.

Sales 308

Sales Marketing 308

MedCity News

APRIL 5, 2024

Contineum Therapeutics plans to spend most of its IPO cash on clinical testing of a lead drug candidate in development for idiopathic pulmonary fibrosis and multiple sclerosis. This small molecule blocks a competitive target pursued by several other companies, including Bristol Myers Squibb and AbbVie. The post J&J-Partnered Contineum Corrals $110M From IPO for Clinical Trials in Fibrosis & MS appeared first on MedCity News.

Competition 118

Competition Leads Biopharma Pharma 118

PharmaTimes

APRIL 5, 2024

Hoxa9 and b-catenin molecules are a rare population of self-renewing HSCs found in bone marrow

Leads 118

Leads 118

Fierce Pharma

APRIL 5, 2024

AstraZeneca's Imfinzi has delivered positive clinical data in another type of lung cancer, building on the immunotherapy’s existing FDA clearance in stage 3 non-small cell lung cancer and extensive | AstraZeneca's Imfinzi has delivered positive clinical data in another type of lung cancer, building on the immunotherapy’s existing FDA clearance in stage 3 non-small cell lung cancer and extensive-stage small cell lung cancer.

FDA 298

FDA 298

MedCity News

APRIL 5, 2024

In today’s tech-savvy world, weaving Health Tech Planning into the fabric of care for older adults is essential. The post Smarter Aging: The Importance of Health Tech Planning appeared first on MedCity News.

117

117

Fierce Pharma

APRIL 5, 2024

Amid ongoing drug shortages and other headline-grabbing issues that fall under the FDA’s purview, the House Committee on Oversight and Accountability is putting the agency’s commissioner Robert Cal | The April 11 hearing could be contentious, as the committee wants to “hold the commissioner accountable" for the FDA's action on drug shortages, among other issues, according to a statement from Chairman James Comer, R-Kentucky.

FDA 290

FDA 290

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

pharmaphorum

APRIL 5, 2024

ADRIATIC trial finds AstraZeneca's cancer immunotherapy Imfinzi improves survival in patients with limited-stage small cell lung cancer (SCLC)

Prospecting 111

Prospecting Patients 111

Fierce Pharma

APRIL 5, 2024

After Novo Holdings set the stage for a $16.5 billion buyout of contract manufacturing giant Catalent earlier this year, its parent company is giving antitrust officials more time for their review | After Novo Holdings pitched a $16.5 billion buyout of Catalent in February, the companies have given the FTC extra time to review the deal.

Manufacturing 246

Manufacturing 246

pharmaphorum

APRIL 5, 2024

Germany's Merck partners Caris Discovery on artificial intelligence-powered discovery of antibody-drug conjugates in a $1.

111

111

MedCity News

APRIL 5, 2024

Beanstalk Benefits vets benefits solutions and aggregates them into a single platform. Employees can build their own benefits portfolio using the platform. The post Startup Launches Out of Redesign Health To Help Employees Build Their Own Benefits appeared first on MedCity News.

110

110

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

APRIL 5, 2024

Cancer Research UK has announced a £58.

Training 108

Training Doctors 108

MedCity News

APRIL 5, 2024

The challenge with the emerging model of “distributive access” is that there isn’t any one individual or entity coordinating everything; patients are left to navigate their own care journeys. And while health systems invested billions of dollars in technology, little of it is well-coordinated or well-orchestrated for the health system, for healthcare workers, or for patients.

Distribution 106

Distribution Healthcare Healthcare Patients 106

Pharmaceutical Commerce

APRIL 5, 2024

In an interwith with Pharma Commerce Editor Nicholas Saraceno, Ed Schoonveld, Value and Access Advisor, Schoonveld Advisory, explains why pharmaceutical products tend to cost more in the US than the rest of the world.

Pharmaceutical 105

Pharmaceutical Pharmaceutical products Pharma 105

pharmaphorum

APRIL 5, 2024

Our regular round-up of financings in the biotech sector is headed by rumours of a $150 to $200 million initial public offering (IPO) for Aardvark Therapeutics, an emerging player in the weight-loss category, alongside a trio of big private rounds.

105

105

Advertisement

Pharmaceutical Commerce

APRIL 5, 2024

The latest news for pharma industry insiders.

Pharma 103

Pharma Medicine 103

PharmaTech

APRIL 5, 2024

Zevtera has been approved to treat three types of bacterial infections and has been granted Priority Review and Fast Track and Qualified Infectious Disease Product designations.

FDA 98

FDA 98

European Pharmaceutical Review

APRIL 5, 2024

Interim data from a Phase I/II clinical trial suggest that mRNA-3927, an investigational mRNA therapy from Moderna, could be a promising treatment for propionic acidaemia. A 70 percent reduction in the risk of metabolic decompensation events was reported by eight participants in the 12-month pretreatment period, according to the trial results published in Nature. “We are excited to share the first published clinical data utilising an mRNA therapy for intracellular protein replacement,̶

Side effects 98

Side effects Safety Patients Leads 98

Pharmaceutical Technology

APRIL 5, 2024

MiNA Therapeutics has entered into an agreement with Nippon Shinyaku to develop RNAa therapeutics for rare neurodegenerative ailments.

97

97

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

PharmaTimes

APRIL 5, 2024

Affecting 80,000 people in England, 12% of brain tumour patients survive beyond five years of diagnosis

Patients 92

Patients 92

pharmaphorum

APRIL 5, 2024

Johnson & Johnson agrees to acquire Shockwave Medical for $13.

Medical 91

Medical 91

PharmaVoice

APRIL 5, 2024

Infectious diseases that were “off the playing field” are now making a comeback.

81

81

Pharmaceutical Technology

APRIL 5, 2024

Recent campaigns have targeted children and young adults in low vaccine uptake areas amidst a rising number of measles cases.

59

59

Advertisement

Distribution

Pharmacy Times

APRIL 5, 2024

Greg Baker, CEO of AffirmedRx, discusses the DRUG Act legislation and its potential impact on curbing rising drug costs through PBM reform.

55

55

Pharmaceutical Technology

APRIL 5, 2024

The director of BARDA’s medical countermeasures programs, Robert Johnson, talks about what the agency is planning to invest in the future.

Medical 59

Medical 59

Clarify Health

APRIL 5, 2024

With new government-mandated price transparency regulations that require healthcare organizations to post their prices online, stakeholders across the industry including patients, providers, and payers, can leverage price insights to make more informed decisions. Health plans can leverage price transparency data to support critical business decisions, design and sculpt provider networks and create stronger partnerships with providers.

Networking 52

Networking Competition Marketing Healthcare 52

Infuse Medical

APRIL 5, 2024

Virtual Reality (VR) technology has revolutionized various industries, including healthcare. In patient education, VR offers a dynamic platform for delivering immersive and interactive experiences. Understanding the fundamentals of VR and its integration into healthcare settings is crucial for maximizing its potential. Understanding Virtual Reality (VR) VR refers to a simulated environment created using computer technology, where users can interact with digital objects and experience sensory fee

Education 52

Education Patients Healthcare Provider Healthcare 52

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales